SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 584 filers reported holding SEAGEN INC in Q2 2023. The put-call ratio across all filers is 1.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,865,000 | +0.3% | 60,639 | -9.0% | 0.06% | +9.6% |
| Q2 2023 | $12,831,000 | -10.5% | 66,667 | -5.9% | 0.05% | -13.3% |
| Q1 2023 | $14,342,000 | +48.7% | 70,833 | -5.6% | 0.06% | +42.9% |
| Q4 2022 | $9,647,000 | -10.3% | 75,071 | -4.5% | 0.04% | -14.3% |
| Q3 2022 | $10,754,000 | -10.6% | 78,596 | +15.7% | 0.05% | -3.9% |
| Q2 2022 | $12,024,000 | +18.7% | 67,956 | -3.4% | 0.05% | +41.7% |
| Q1 2022 | $10,129,000 | -8.6% | 70,317 | -2.0% | 0.04% | -2.7% |
| Q4 2021 | $11,088,000 | -12.3% | 71,721 | -3.7% | 0.04% | -17.8% |
| Q3 2021 | $12,650,000 | +5.2% | 74,498 | -2.2% | 0.04% | +7.1% |
| Q2 2021 | $12,026,000 | +28.6% | 76,174 | +13.1% | 0.04% | +13.5% |
| Q1 2021 | $9,351,000 | -15.3% | 67,341 | +6.8% | 0.04% | -26.0% |
| Q4 2020 | $11,040,000 | +15.1% | 63,036 | +28.6% | 0.05% | -3.8% |
| Q3 2020 | $9,593,000 | – | 49,021 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |